Elisa Camela

39PUBLICATIONS
17CO-AUTHORS
Pharmaceutical delivery technologiesSocial and personality psychology not elsewhere classifiedPharmacogenomicsEnvironmental epidemiologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Apr 26, 2026
Deucravacitinib in moderate-to-severe plaque psoriasis: a real-world study of effectiveness and safety in clinical practice.

|Mar 12, 2024
Dupilumab in real-life settings: a review of adverse events and their pathogenesis.

Elisa Camela, Anna Rita Giampetruzzi, Ornella De Pità

|Sep 28, 2023
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation.

Luca Potestio, Elisa Camela, Sara Cacciapuoti

|Aug 26, 2023
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.

Luca Potestio, Teresa Battista, Sara Cacciapuoti

|Aug 10, 2023
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review.

Luca Potestio, Elisa Camela, Sara Cacciapuoti

|Jul 05, 2023
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?

Matteo Megna, Elisa Camela, Angelo Ruggiero

Pageof 7

Frequent Collaborators

27 joint publications

Matteo Megna

25 joint publications

Luca Potestio

19 joint publications

Gabriella Fabbrocini

17 joint publications

Angelo Ruggiero